WiCON International Group has recently reached agreement with a number of major US investment firms to help them identify, screen and negotiate with potential M&A opportunities in the Chinese pharmaceutical industry.

Ideal candidates should be profitable, have at least an annual sales of RMB 200 million, and need equity investment at and above US$20 million.

Interested party please contact us at (010) 62354966 ext. 801 or e-mail: jshen@jicaipharma.com. 

    维康医药集团与数家美国中大型投资机构最近达成协议，协助他们在华寻找合适的中国制药企业进行战略投资。现寻求满足以下要求的中国药企：业绩良好，拥有较好的产品线，具有中长期发展潜力，目前年销售额在2亿以上，寻求战略投资数额在2000万美元以上。

    有意者可以与我公司联络（010）62354966转801或电邮：jshen@jicaipharma.com.